Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Siemens Makes PHM Debut With Partner IBM; Verily, 3M Also Link Arms

Executive Summary

Siemens Healthineers will be offering population health management solutions for the first time, as it teams up with IBM Watson Health. Verily and 3M are also joining the PHM partnering wave.

You may also be interested in...



Siemens Strengthens POC Informatics Offering With Conworx Tech

Siemens Healthineers has acquired informatics firm Conworx Technology GmbH to form Siemens Healthineers Point of Care Informatics, which aims to increase connectivity between POC diagnostic products.

IBM Enriches Health Data Mine With Truven

IBM says its Watson Health division will boast “the largest and most diverse” repositories of health-related data, after sealing a $2.6bn deal to acquire Truven Health Analytics. The deal, IBM’s fourth healthcare data-related acquisition in less than 12 months, will bring more than 8,500 new clients, including US federal and state government agencies, employers, health plans, hospitals, clinicians and life sciences companies, to Watson Health’s portfolio.

IBM makes billion-dollar buy to improve medical image management

IBM has racked up its third and largest healthcare acquisition this year with a $1bn agreement to buy Merge Healthcare Inc, a specialist in medical image handling and processing.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT103960

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel